Advertisement



Johnson & Johnson Begins Enrollment in Pivotal Studies Evaluating First-of-its-Kind Carotid IVL Platform

Based on information published by Johnson & Johnson Press Releases (linked below the article). How we report

· U.S. IDE study program will evaluate the purpose-built Shockwave™ SkyRunner Carotid IVL System designed to address the challenges of calcification in carotid arteries prior to stenting · Clinical program is part of Johnson & Johnson’s plan to enhance treatment options for patients with carotid artery disease, which accounts for up to one-third of all strokes


Advertisement



Important: this content is for informational purposes only and is not medical advice, a prescribing instruction, or a recommendation to act. Consult a licensed healthcare professional before taking any medication.


Related News

Advertisement